Research
Print page Print page
Switch language
Rigshospitalet - a part of Copenhagen University Hospital
Published

Synergistic effect of immunomodulatory S100A8/A9 and ciprofloxacin against Pseudomonas aeruginosa biofilm in a murine chronic wound model

Research output: Contribution to journalJournal articleResearchpeer-review

DOI

  1. Editorial: The complexity of microbial biofilm research-an introduction to the third thematic issue on biofilms

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Increased bactericidal activity of colistin on Pseudomonas aeruginosa biofilms in anaerobic conditions

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Autofluorescence in samples obtained from chronic biofilm infections - "all that glitters is not gold"

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Azithromycin potentiates avian IgY effect against Pseudomonas aeruginosa in a murine pulmonary infection model

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Early IL-2 treatment of mice with Pseudomonas aeruginosa pneumonia induced PMN-dominating response and reduced lung pathology

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. The environmental occurrence of Pseudomonas aeruginosa

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Antibiotic therapy as personalized medicine - general considerations and complicating factors

    Research output: Contribution to journalReviewResearchpeer-review

View graph of relations

The majority of chronic wounds are associated with bacterial biofilms recalcitrant to antibiotics and host responses. Immunomodulatory S100A8/A9 is suppressed in Pseudomonas aeruginosa biofilm infected wounds. We aimed at investigating a possible additive effect between S100A8/A9 and ciprofloxacin against biofilms. Materials/methods: Thirty-two mice were injected with alginate-embedded P. aeruginosa following a third-degree burn. The mice were randomized into four groups receiving combination ciprofloxacin and S100A8/A9 or monotherapy ciprofloxacin, S100A8/A9 or a placebo and evaluated by host responses and quantitative bacteriology in wounds. In addition, in vitro checkerboard analysis was performed, with P. aeruginosa and ascending S100A8/A9 and ciprofloxacin concentrations. Results: S100A8/A9 augmented the effect of ciprofloxacin in vivo by lowering the bacterial quantity compared to the placebo arm and the two monointervention groups (P < 0.0001). S100A8 and 100A9 were increased in the double-treated group as compared to the monointervention groups (P = 0.032, P = 0.0023). Tissue inhibitor of metalloproteinases-1 and keratinocyte\chemokine chemoattractant-1 were increased in the double-intervention group compared to the S100A8/A9 group (P = 0.050, P = 0.050). No in vitro synergism was detected. Conclusion: The observed ciprofloxacin-augmenting effect of S100A8/A9 in vivo was not confirmed by checkerboard analysis, indicating dependence on host cells for the S100A8/A9 effect. S100A8/A9 and ciprofloxacin is a promising therapy for optimizing chronic wound treatment.

Original languageEnglish
Article numberftz027
JournalPathogens and Disease
Volume78
Issue number5
ISSN2049-632X
DOIs
Publication statusPublished - 1 Jul 2020

Bibliographical note

© FEMS 2020.

    Research areas

  • Biofilm, Flouroquinolone, Pseudomonas

ID: 57229715